Abscopal effects were observed by strategies to improve cross-priming of anti-tumor T cells including stimulation of DC by Flt3-Ligand [47], treatment with GM-CSF [49, 50], DC [51], anti-PD1 [48] and anti-CTLA-4 antibodies [43, 52, 53]. The gene discussed is CSF2; the disease is neoplasm.